Home › Studies › PRJEB8094
PRJEB8094 ERP009131

Healthy adults, cefprozil antibiotic trial, Canada

The initial state of the human gut microbiome determines its reshaping by antibiotics

71 stool samples from healthy adult volunteers in Canada, collected before, at the end of and three months after cefprozil antibiotic treatment, to study individual gut microbiome responses and resistance genes. machine-written summary

72 samples · 1,252 runs · CA · Adult · 2015 · 13.55 Gbp / sample

Sources
✓Sequence archive 914✓Abstract / description 1✓Full text 2○Supplementary tables✓External resources 159–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive914 sample values (age, antibiotic exposure, bmi, collection date, country, intervention, intervention detail, latitude)
✓ Abstract / description1 sample values (health condition detail)
✓ Full text2 sample values (health condition, location region) · PMC10036994, PMC10408196, PMC10536327, PMC11121782, PMC12084026, PMC12390848, PMC12764784, PMC13269251, PMC4817689, PMC5154369, PMC6123480, PMC6425642, PMC6451232, PMC6520913, PMC6789009, PMC8288446, PMC9022020, PMC9621045
○ Supplementary tablesfiles read; no table could be matched to the samples
✓ External resources159 sample values (antibiotic exposure, health condition, health condition detail) · from curatedMetagenomicData 3 (cMD 3), GMrepo v3
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

before · no interventionbefore · no interventi24 samplesantibioticantibiotic48 samples
single arm: samples before and on the intervention

24 people have samples in more than one arm.

Antibiotic given as the study intervention (incl. eradication therapy design single_arm_before_after · population healthy_control · Cefprozil (second-generation cephalosporin), 7-day course, healthy volunteers

“administered a second-generation cephalosporin, cefprozil” — abstract:26359913 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
adult72
Condition
healthy_control72
Sex
female39
male33
Country
CA72
Body site
primary72
Collected 2011–2014
2011: 6 samples2012: 32 samples2013: 33 samples2014: 1 samples20112014
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 19 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 53 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 13.55 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

24 of 24 people sampled more than once (72 samples; median 3, up to 3 per person) · follow-up median 3 mo (max 3 mo) · median interval between samples 3 mo (time from collection dates). Schedule stated by the source: “Stool before antibiotic exposure (D0), at end of 7-day treatment (D7), and three months later” (time origin: unknown).

11: day 01: day 71: day 951010: day 010: day 710: day 971111: day 011: day 711: day 981212: day 012: day 812: day 1041313: day 013: day 813: day 921414: day 014: day 814: day 921515: day 015: day 815: day 911717: day 017: day 717: day 1001818: day 018: day 718: day 991919: day 019: day 719: day 9922: day 02: day 72: day 982020: day 020: day 720: day 982121: day 021: day 821: day 982222: day 022: day 722: day 992323: day 023: day 723: day 972525: day 025: day 625: day 9833: day 03: day 73: day 983838: day 038: day 738: day 9944: day 04: day 64: day 9855: day 05: day 75: day 9766: day 06: day 06: day 9877: day 07: day 77: day 9788: day 08: day 78: day 9199: day 09: day 79: day 1050 d26 d52 d3 mo3 mo

Each row is one person (24 shown); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Bacteroides 22.8%Alistipes 9.7%Phocaeicola 8.9%Prevotella 5.9%Parabacteroides 4.8%Vescimonas 2.3%Acetatifactor 2.1%Faecalibacterium 2.1%Oscillibacter 1.6%Hominicoprocola 1.5%Akkermansia 1.4%Dialister 1.4%not assigned to a genus 13.2%other genera 22.4%

Genera, mean relative abundance over 71 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category72 100%
country72 100%72
health_condition72 100%711
subject_id72 100%72
age_at_collection_days72 100%72
bmi72 100%72
collection_date72 100%72
detailed_location72 100%
health_condition_detail72 100%711
intervention72 100%72
location_region72 100%711
sex72 100%72
timepoint_label72 100%72
antibiotic_exposure71 99%5417
intervention_detail71 99%71
latitude71 99%71
longitude71 99%71
Papers (18)
13 more
  • Characterization of vancomycin-resistance vanD gene clusters in the human intestinal microbiota by metagenomics and culture-enriched metagenomics. 2023 PMID 36968950 PMC10036994
  • GePMI: A statistical model for personal intestinal microbiome identification. 2018 PMID 30210803 PMC6123480
  • Individualized recovery of gut microbial strains post antibiotics. 2019 PMID 31632686 PMC6789009
  • Dispersal strategies shape persistence and evolution of human gut bacteria. 2021 PMID 34111423 PMC8288446
  • Early indicators of microbial strain dysbiosis in the human gastrointestinal microbial community of certain healthy humans and hospitalized COVID-19 patients. 2022 PMID 35449389 PMC9022020
  • Functional profile of host microbiome indicates Clostridioides difficile infection. 2022 PMID 36289064 PMC9621045
  • Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions. 2023 PMID 37553697 PMC10408196
  • Uncovering Predictive Factors and Interventions for Restoring Microecological Diversity after Antibiotic Disturbance. 2023 PMID 37764709 PMC10536327
  • Bacteroidales-Specific Antimicrobial Genes Can Influence the Selection of the Dominant Fecal Strain of Bacteroides vulgatus and Bacteroides uniformis from the Gastrointestinal Tract Microbial Community. 2024 PMID 38792577 PMC11121782
  • Microbes with higher metabolic independence are enriched in human gut microbiomes under stress. 2025 PMID 40377187 PMC12084026
  • Microbiota-driven antitumour immunity mediated by dendritic cell migration. 2025 PMID 40659786 PMC12390848
  • The gut methanotroph Methylocystis intestini modulates intestinal peristalsis and fat metabolism via reducing methane levels. 2025 PMID 41331251 PMC12764784
  • Strain transmission links human microbiomes along the oral-gut axis and across cohabiting individuals. 2026 PMID 42312244 PMC13269251
Details
Archive description

The human gut microbiota is affected by antibiotics, but the heterogeneous response between individuals remains unexplored. To specifically address this question and examine the effect of antibiotics on selection of resistance genes, we administered the second-generation cephalosporin cefprozil to healthy volunteers. Stool samples gathered before antibiotic exposure, at the end of the treatment and three months later were analyzed using shotgun metagenomic sequencing. We show that normal antibiotic treatment can alter the gut microbiome in a specific, reproducible and predictable fashion. Strikingly, we identified a subgroup of participants that were enriched in opportunistic pathogen Enterobacter cloacae after exposure to the antibiotic, an effect linked to lower initial microbiome diversity and to the Bacteroides enterotype. Resistance genes that were not detectable before the treatment were observed after a 7-day course of antibiotic. Knowledge of the initial composition of the microbiome could assist in the prevention of the adverse effects of antibiotics.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “of the human gut microbiome determines its”
  • body site study.description · “The human gut microbiota is affected”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • life stage study.description · “cefprozil to healthy volunteers . Stool samples”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA3182045age_at_collection_days10601.0R10.85sample.attr.host_age29
SAMEA3182045antibiotic_exposurenoR10.70sample.name_rule:aliasP1E0
SAMEA3182093antibiotic_exposureyesR20.75external.cmd sourceantibiotics_current_use: Yes
SAMEA3182045bmi22.16R10.85biosample.attribute:host height+host total massheight 1.9 m; mass 80 kg
SAMEA3182097bmi24.72R10.80biosample.attribute:host total mass;host heighthost total mass: 79.2; host height: 1.79
SAMEA3182045collection_date2011-11-01R10.90biosample.attribute:collection_date2011-11-01
SAMEA3182097collection_date2012-05-15R10.85biosample.attribute:collection datecollection date: 2012-05-15
SAMEA3182045countryCAR10.90sample.attr.geographic_location_country_and_or_seaCanada
SAMEA3182045health_conditionhealthy_controlR20.75external.cmd sourcedisease: Healthy
SAMEA3182069health_conditionhealthy_controlR20.75external.gmrepo sourcephenotype: Health
SAMEA3182097health_conditionhealthy_controlR30.70paper.fulltext.methods24 healthy participants enrolled in this study
SAMEA3182045health_condition_detailHealthyR20.75external.cmd sourcedisease: Healthy
SAMEA3182069health_condition_detailHealthR20.75external.gmrepo sourcephenotype: Health
SAMEA3182097health_condition_detailHealthy volunteers with no stated disease conditionR40.50study.descriptionhealthy volunteers
SAMEA3182045interventionno_interventionR10.80biosample.attribute:TimepointTimepoint: 0
SAMEA3182097interventionantibioticR10.85biosample.attribute:TypeType: Exposed
SAMEA3182045intervention_detailTimepoint = 0 (before intervention start)R10.80biosample.attribute:TimepointTimepoint: 0
SAMEA3182045latitude46.8033R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude46.8032826 -71.242796
SAMEA3182045location_regionQuebecR10.60biosample.attribute:geographic_location_latitude+geographic_location_longitude46.8032826 -71.242796
SAMEA3182097location_regionQuebec City regionR30.70paper.fulltext.methodsyoung adults from the Quebec City region (Canada)
SAMEA3182045longitude-71.2428R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude46.8032826 -71.242796
SAMEA3182045sexmaleR10.90sample.attr.host_sexmale
SAMEA3182045subject_id1R10.85sample.attr.host_subject_id1
SAMEA3182097subject_id5R10.85biosample.attribute:host subject idhost subject id: 5
SAMEA3182045timepoint_label0R10.85sample.attr.timepoint0
SAMEA3182097timepoint_label90R10.85biosample.attribute:TimepointTimepoint: 90
Sequencing

1,252 runs over 72 samples · mean 0.78 Gbp per run (median 0.81 Gbp, total 982.56 Gbp; 1,252 runs with a base count) · layout PAIRED 1,252 · platform ILLUMINA 1,252 · models Illumina HiSeq 1000 (1,252) · 90% of runs with a Sandpiper profile · first public 2015-03-05

Authors (84)

Raymond F first · Ouameur AA · Déraspe M · Iqbal N · Gingras H · Dridi B · Leprohon P · Plante PL · Giroux R · Bérubé · Bérubé È · Frenette J · Boudreau DK · Simard JL · Chabot I · Domingo MC · Trottier S · Boissinot M · Huletsky A · Roy PH · Ouellette M · Bergeron MG · Corbeil J last · Koo H first · Morrow CD last · Orihara K first · Yahagi K · Saito Y · Watanabe Y · Sasai T · Hara T · Tsukuda N · Oki K · Fujimoto J · Matsuki T last · Chen J first · Zhu J · Lu W · Wang H · Pan M · Tian P · Zhao J · Zhang H · Chen W last · Mancabelli L first · Milani C · De Biase R · Bocchio F · Fontana F · Lugli GA · Alessandri G · Tarracchini C · Viappiani A · De Conto F · Nouvenne A · Ticinesi A · Bussolati O · Meschi T · Cecchi R · Turroni F · Ventura M last · van Sinderen D · Schroer HW first · Beghini F · Raygoza Garay JA · Christakis NA · Bosch DE last · Heidrich V first · Fackelmann G · Ricci L · Spadazzi R · Baldanzi G · Punčochář M · Catassi G · Marchi P · Modesto M · Piccinno G · Porcari S · Rondinella D · Asnicar F · Valles-Colomer M · Mattarelli P · Ianiro G · Segata N last

Downloads

PRJEB8094.csv.gz (3.8 KB) · parquet (75.9 KB) — all 72 samples, every field with route and confidence · PRJEB8094_determinations.csv.gz (11.3 KB) — 1,076 evidence rows

Samples (72 · every field this project has values for · hover a cell for its source)
Loading the sample table…